• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【药物名称】Sulcephalosporin, Cefsulodin sodium, SCE-129, CGP-7174/E, Abbott-46811, Tilmapor, Takesulin, Pseudomonil, Pseudocef, Monaspor

【化学名称】4-Carbamoyl-1-[[(6R,7R)-2-carboxy-8-oxo-7-[(2R)-2-phenyl-2-sulfoacetamido]-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]pyridinium hydroxide,inner salt,sodium salt
      [6R-[6alpha,7beta(R*)]]-4-(Aminocarbonyl)-1,2-[[2-carboxy-8-oxo-7-[(phenylsulfoacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]pyridinium hydroxide,inner salt,sodium salt

【CA登记号】52152-93-9, 62587-73-9 (free acid)

【 分 子 式 】C22H19N4NaO8S2

【 分 子 量 】554.53653

【开发单位】Novartis (Originator), Takeda (Originator)

【药理作用】Antibiotics, ANTIINFECTIVE THERAPY, Cephalosporins

合成路线1

The reaction of 7-aminocephalosporanic acid (I) with alpha-sulfophenylacetyl chloride (II) by means of NaOH and NaHCO3 in ether gives 7-(alpha-sulfophenylacetamido)cephalosporanic acid (III), which is then condensed with isonicotinamide (IV) by means of KSCN and pyridine in water.

1 Nomura, H.; et al.; Semisynthetic beta-lactams antibiotics. VII. New semisynthetic cephalosporins derived from alpha-sulfophenylacetic acid. Heterocycles 1974, 2, 1, 67-72.
2 Morimoto, S.; et al.; Cephalosporin compounds. DE 2234280; ES 404745; FR 2146313; NL 7209811 .
3 Nomura, H.; et al.; Semisynthetic beta-lactam antibiotics. 6. Sulfocephalosporins and their antipseudomonal activities. J Med Chem 1974, 17, 12, 1312-15.
4 Blancafort, P.; Castaner, J.; Serradell, M.N.; Sweetman, A.J.; Cefsulodin. Drugs Fut 1980, 5, 2, 67.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 22747 (6R,7R)-3-[(acetoxy)methyl]-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid C10H12N2O5S 详情 详情
(II) 32665 (1S)-2-chloro-2-oxo-1-phenyl-1-ethanesulfonic acid C8H7ClO4S 详情 详情
(III) 32666 (6R,7R)-3-[(acetoxy)methyl]-8-oxo-7-[[(2S)-2-phenyl-2-sulfoethanoyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid C18H18N2O9S2 详情 详情
(IV) 25191 isonicotinamide 1453-82-3 C6H6N2O 详情 详情
Extended Information